Latest cancers Stories
Pembrolizumab Demonstrated 28 Percent Overall Response Rate and 76 Percent Disease Control Rate in Difficult-to-Treat Cancer First Findings from KEYNOTE-028, Merck's Innovative
The opportunity to make progress through a coalition of strategic partners is tempered by increasing incidence and death rates. NEWPORT BEACH, Calif., April 9, 2015 /PRNewswire-USNewswire/
According to the new report from BCC Research, the global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014.
Dental associations urge regular oral cancer examinations--early detection saves lives! ROSEMONT, Ill., April 2, 2015 /PRNewswire-USNewswire/ -- When oral and oropharyngeal cancers (cancers
LONDON, March 18, 2015 /PRNewswire/ -- REPORT HIGHLIGHTSThe global market for "silent" cancers was valued at $8.5 billion in 2013 and $9 billion in 2014.
Deadliest Cancers Coalition Calls on Congress to provide A Meaningful Increase for the NCI in FY2016 WASHINGTON, March 10, 2015 /PRNewswire-USNewswire/ -- As budget discussions heat
Research Presented at 2015 Genitourinary Cancers Symposium Provides Potential Implications for Choice of Therapy and Clinical Trial Participation IRVING, Texas, Feb.
LOS ANGELES, Dec. 23, 2014 /PRNewswire/ -- The Farrah Fawcett Foundation, created by Ms.
Active Immunotherapy Targets hTERT Gene Associated with 85% of Cancers PLYMOUTH MEETING, Pa., Dec. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Study May Lead to More Targeted Treatments for Cancers and "Rasopathies" CINCINNATI, Nov.
- Growing in low tufty patches.